These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 11137572

  • 1. Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR.
    Zhang GX, Xiao BG, Yu LY, van der Meide PH, Link H.
    J Neuroimmunol; 2001 Feb 01; 113(1):10-8. PubMed ID: 11137572
    [Abstract] [Full Text] [Related]

  • 2. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
    Duan RS, Adikari SB, Huang YM, Link H, Xiao BG.
    Neurobiol Dis; 2004 Jul 01; 16(2):461-7. PubMed ID: 15193302
    [Abstract] [Full Text] [Related]

  • 3. Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals.
    Shi FD, Bai XF, Li HL, Huang YM, Van der Meide PH, Link H.
    Clin Exp Immunol; 1998 Mar 01; 111(3):506-12. PubMed ID: 9528890
    [Abstract] [Full Text] [Related]

  • 4. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG, Duan RS, Zhu WH, Lu CZ.
    Cell Immunol; 2006 Jun 01; 241(2):95-101. PubMed ID: 17005165
    [Abstract] [Full Text] [Related]

  • 5. Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4.
    Im SH, Barchan D, Maiti PK, Fuchs S, Souroujon MC.
    J Immunol; 2001 Jun 01; 166(11):6893-8. PubMed ID: 11359850
    [Abstract] [Full Text] [Related]

  • 6. Linomide suppresses both Th1 and Th2 cytokines in experimental autoimmune myasthenia gravis.
    Zhang GX, Yu LY, Shi FD, Xiao BG, Björk J, Hedlund G, Link H.
    J Neuroimmunol; 1997 Mar 01; 73(1-2):175-82. PubMed ID: 9058774
    [Abstract] [Full Text] [Related]

  • 7. Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis.
    Wang HB, Shi FD, Li H, van der Meide PH, Ljunggren HG, Link H.
    Clin Immunol; 2000 May 01; 95(2):156-62. PubMed ID: 10779409
    [Abstract] [Full Text] [Related]

  • 8. Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor.
    Yi HJ, Chae CS, So JS, Tzartos SJ, Souroujon MC, Fuchs S, Im SH.
    Mol Immunol; 2008 Nov 01; 46(1):192-201. PubMed ID: 18799218
    [Abstract] [Full Text] [Related]

  • 9. Modulation of immune responses and suppression of experimental autoimmune myasthenia gravis by surgical denervation of the spleen.
    Bakhiet M, Yu LY, Ozenci V, Khan A, Shi FD.
    Clin Exp Immunol; 2006 May 01; 144(2):290-8. PubMed ID: 16634803
    [Abstract] [Full Text] [Related]

  • 10. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and IL-10 relates to resistance to experimental autoimmune myasthenia gravis (EAMG) in young Lewis rats.
    Shi FD, Zhang GX, Bai XF, Van der Meide PH, Link H.
    Clin Exp Immunol; 1997 Jun 01; 108(3):523-8. PubMed ID: 9182902
    [Abstract] [Full Text] [Related]

  • 11. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
    Ulusoy C, Çavuş F, Yılmaz V, Tüzün E.
    Immunol Invest; 2017 Jul 01; 46(5):490-499. PubMed ID: 28375749
    [Abstract] [Full Text] [Related]

  • 12. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells.
    Ma CG, Zhang GX, Xiao BG, Wang ZY, Link J, Olsson T, Link H.
    Ann N Y Acad Sci; 1996 Feb 13; 778():273-87. PubMed ID: 8610980
    [Abstract] [Full Text] [Related]

  • 13. Induction of peripheral tolerance to experimental autoimmune myasthenia gravis by acetylcholine receptor-pulsed dendritic cells.
    Xiao BG, Duan RS, Link H, Huang YM.
    Cell Immunol; 2003 May 13; 223(1):63-9. PubMed ID: 12914759
    [Abstract] [Full Text] [Related]

  • 14. Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18.
    Im SH, Barchan D, Maiti PK, Raveh L, Souroujon MC, Fuchs S.
    FASEB J; 2001 Oct 13; 15(12):2140-8. PubMed ID: 11641240
    [Abstract] [Full Text] [Related]

  • 15. Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis.
    Shi FD, Bai XF, Xiao BG, van der Meide PH, Link H.
    J Neurol Sci; 1998 Feb 18; 155(1):1-12. PubMed ID: 9562316
    [Abstract] [Full Text] [Related]

  • 16. B cell autoimmunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis.
    Wang ZY, Link H, Qiao J, Olsson T, Huang WX.
    J Neuroimmunol; 1993 Jun 18; 45(1-2):103-12. PubMed ID: 8331155
    [Abstract] [Full Text] [Related]

  • 17. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY, Link H, Ljungdahl A, Höjeberg B, Link J, He B, Qiao J, Melms A, Olsson T.
    Cell Immunol; 1994 Sep 18; 157(2):353-68. PubMed ID: 7520837
    [Abstract] [Full Text] [Related]

  • 18. Dendritic cells exposed in vitro to TGF-beta1 ameliorate experimental autoimmune myasthenia gravis.
    Yarilin D, Duan R, Huang YM, Xiao BG.
    Clin Exp Immunol; 2002 Feb 18; 127(2):214-9. PubMed ID: 11876742
    [Abstract] [Full Text] [Related]

  • 19. Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats.
    Saoudi A, Bernard I, Hoedemaekers A, Cautain B, Martinez K, Druet P, De Baets M, Guéry JC.
    J Immunol; 1999 Jun 15; 162(12):7189-97. PubMed ID: 10358165
    [Abstract] [Full Text] [Related]

  • 20. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
    Zhang GX, Xiao BG, Bai XF, van der Meide PH, Orn A, Link H.
    J Immunol; 1999 Apr 01; 162(7):3775-81. PubMed ID: 10201893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.